BREAST LOBULAR CARCINOMA IN SITU
Clinical trials for BREAST LOBULAR CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST LOBULAR CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST LOBULAR CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a lower tamoxifen dose prevent breast cancer in High-Risk women?
Prevention Recruiting nowThis study is for premenopausal women at higher-than-average risk for breast cancer. It tests whether a low dose of tamoxifen, adjusted based on each woman's response, can safely reduce breast density—a key risk factor for breast cancer. About 200 women will take part, and the go…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 26, 2026 06:09 UTC
-
New study tests tamoxifen and Omega-3 combo to slash breast cancer risk in overweight women
Prevention Recruiting nowThis study looks at whether taking low-dose tamoxifen, alone or with high-dose omega-3 fatty acids, can lower breast cancer risk in overweight or obese postmenopausal women who are already at higher risk. About 66 women will take part. The goal is to see if adding omega-3s improv…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 22, 2026 14:05 UTC
-
New hope for High-Risk women: can acolbifene outdo tamoxifen in breast cancer prevention?
Prevention Recruiting nowThis study tests two drugs, acolbifene and low-dose tamoxifen, to see which works better at preventing breast cancer in premenopausal women at high risk. Both drugs block estrogen from fueling breast cell growth. About 80 women will take one of the drugs for six months, and resea…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 14, 2026 12:05 UTC